drugset / Trial / NCT02181296

Pulmonary Function and Interscalene Block

NCT02181296 ↗

Completed 50 enrolled University of Pennsylvania
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of our study is to compare the degree of phrenic nerve blockade after interscalene block using 0.1% ropivacaine or 0.2% ropivacaine. Our hypothesis is that using a lower concentration of local anesthetic will result in lesser degree of phrenic nerve block. 40 patients will be enrolled. Half will receive the block with 0.1% ropivacaine and half with 0.2% ropivacaine. Phrenic nerve and diaphragm function will be assessed by bedside spirometry and ultrasound visualization.

Timeline

Start
2014-07
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified 0.1 % —
Comparator Ropivacaine Other / unclassified 0.2 % —

Indications

No indication recorded.